News & Views

Hypertension: New US blood-pressure guidelines — who asked the patients?

The radical new US hypertension guidelines, released 3 years after the previous scientific statement, have implications far beyond their intended recipients. They include a new definition for hypertension, lower treatment targets, and extended guidance on the implementation of multidisciplinary care, including self-monitoring of blood pressure. Some recommendations are likely to generate controversy.

  • Subscribe to Nature Reviews Cardiology for full access:

    $199

    Subscribe

Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.

References

  1. 1.

    et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. (2017).

  2. 2.

    et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2224–2260 (2012).

  3. 3.

    et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 387, 957–967 (2016).

  4. 4.

    et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103–2116 (2015).

  5. 5.

    et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117, 743–753 (2008).

  6. 6.

    et al. Effects of labelling on income, work and social function among hypertensive employees. J. Chron. Dis. 37, 417–423 (1984).

  7. 7.

    , & Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ 345, e3953 (2012).

  8. 8.

    & Association of blood pressure lowering with mortality and cardiovascular disease across blood pressure levels: a systematic review and meta-analysis. JAMA Intern. Med. (2017).

  9. 9.

    et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J. Hypertens. 24, 1201–1208 (2006).

  10. 10.

    , & Patient preferences for cardiovascular preventive medication: a systematic review. Heart 103, 1578–1586 (2017).

Download references

Acknowledgements

R.J.M. is funded by an NIHR Professorship (NIHR-RP-R2-12-015) and the NIHR Oxford CLAHRC.

Author information

Affiliations

  1. Richard J. McManus is at the Nuffield Department of Primary Care Health Sciences, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford OX2 6GG, UK.

    • Richard J. McManus
  2. Jonathan Mant is at the Primary Care Unit, Department of Public Health & Primary Care, Strangeways Research Laboratory, University of Cambridge, Cambridge CB1 8RN, UK.

    • Jonathan Mant

Authors

  1. Search for Richard J. McManus in:

  2. Search for Jonathan Mant in:

Competing interests

R.J.M. has received blood pressure monitoring equipment for research purposes from Lloyds Pharmacies and Omron. J.M. declares no competing interests.

Corresponding author

Correspondence to Richard J. McManus.